Target intelligence / Profile preview

Enterovirus 71 capsid protein VP1 BC loop epitope (EV71 VP1 BC loop)

Target
EV71 VP1 BC loop
Molecular classification
Viral capsid protein, Epitope, Antigenic site
01

Overview

The Enterovirus 71 (EV71) capsid VP1 BC loop epitope is a critical antigenic region located on the surface of the viral capsid, specifically within the VP1 structural protein [1, 4]. This loop, typically comprising residues 97 to 105, is positioned near the five-fold icosahedral axis of the virion and is highly exposed to the host immune system [4, 14]. Biologically, the BC loop plays a significant role in viral pathogenesis, including mediating cell tropism and participating in the conformational changes necessary for viral uncoating and RNA release [2, 12]. Mutations in this region, such as the L97R substitution, have been linked to increased neurotropism and virulence in central nervous system infections [2, 3]. As a therapeutic target, the VP1 BC loop is a primary focus for the development of vaccines and neutralizing monoclonal antibodies [1, 5]. It contains potent neutralizing epitopes that, when targeted by antibodies, can inhibit viral attachment and entry into host cells [5, 9]. Furthermore, the loop's structural flexibility makes it a versatile site for the insertion of foreign peptides in the design of recombinant or multivalent vaccines against hand, foot, and mouth disease (HFMD) [4, 10]. Therapeutic strategies targeting this epitope aim to elicit a robust humoral immune response to prevent the severe neurological and systemic complications associated with EV71 infection [11, 15].

Other names
VP1 BC loopBC loop of VP1Enterovirus 71 VP1 BC loopEV71 VP1 BC loopVP1 residues 97-105
02

Mechanism of action

Neutralization of viral infectivity by blocking receptor binding, viral internalization, or uncoating; induction of protective humoral immunity.

03

Biological functions

Viral attachmentViral entryViral uncoatingImmune response
04

Disease associations

Hand, foot, and mouth diseaseEncephalitisAseptic meningitisAcute flaccid paralysisPulmonary edema
05

Safety considerations

Viral escape mutationsAntibody-dependent enhancement (ADE)Cross-reactivity with host proteins
06

Interacting drugs

Inactivated Enterovirus 71 vaccine

2 more in the full profile.

07

Biomarkers

Anti-EV71 VP1 antibody titerNeutralizing antibody titer

Beyond the preview

Go deeper on Enterovirus 71 capsid protein VP1 BC loop epitope (EV71 VP1 BC loop).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enterovirus 71 capsid protein VP1 BC loop epitope (EV71 VP1 BC loop).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call